25 XP   0   0   10

MediciNova Inc
Buy, Hold or Sell?

Let's analyse Medicinova together

PenkeI guess you are interested in MediciNova Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of MediciNova Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about MediciNova Inc

I send you an email if I find something interesting about MediciNova Inc.

Quick analysis of Medicinova (30 sec.)










What can you expect buying and holding a share of Medicinova? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$1.27
Expected worth in 1 year
$1.11
How sure are you?
32.5%

+ What do you gain per year?

Total Gains per Share
$-0.16
Return On Investment
-12.1%

For what price can you sell your share?

Current Price per Share
$1.32
Expected price per share
$1.26 - $2.09
How sure are you?
50%

1. Valuation of Medicinova (5 min.)




Live pricePrice per Share (EOD)

$1.32

Intrinsic Value Per Share

$-0.52 - $0.31

Total Value Per Share

$0.76 - $1.58

2. Growth of Medicinova (5 min.)




Is Medicinova growing?

Current yearPrevious yearGrowGrow %
How rich?$62.3m$75m-$10m-15.5%

How much money is Medicinova making?

Current yearPrevious yearGrowGrow %
Making money-$2.1m-$3.4m$1.3m61.1%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Medicinova (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#447 / 1010

Most Revenue
#56 / 1010

Most Profit
#307 / 1010

Most Efficient
#222 / 1010

What can you expect buying and holding a share of Medicinova? (5 min.)

Welcome investor! Medicinova's management wants to use your money to grow the business. In return you get a share of Medicinova.

What can you expect buying and holding a share of Medicinova?

First you should know what it really means to hold a share of Medicinova. And how you can make/lose money.

Speculation

The Price per Share of Medicinova is $1.32. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Medicinova.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Medicinova, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.27. Based on the TTM, the Book Value Change Per Share is $-0.04 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.07 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Medicinova.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.04-3.2%-0.04-3.3%-0.07-5.4%-0.06-4.6%-0.06-4.4%
Usd Book Value Change Per Share-0.05-3.5%-0.04-3.0%-0.07-5.2%-0.01-0.8%0.021.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.05-3.5%-0.04-3.0%-0.07-5.2%-0.01-0.8%0.021.4%
Usd Price Per Share1.50-2.01-2.36-4.27-5.02-
Price to Earnings Ratio-8.93--15.82--8.26--33.62--40.59-
Price-to-Total Gains Ratio-32.11--80.19--34.52-1.23-464.24-
Price to Book Ratio1.18-1.51-1.53-2.79-5.04-
Price-to-Total Gains Ratio-32.11--80.19--34.52-1.23-464.24-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.32
Number of shares757
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.04-0.01
Usd Total Gains Per Share-0.04-0.01
Gains per Quarter (757 shares)-30.34-8.28
Gains per Year (757 shares)-121.37-33.12
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-121-1310-33-43
20-243-2520-66-76
30-364-3730-99-109
40-485-4940-132-142
50-607-6150-166-175
60-728-7360-199-208
70-850-8570-232-241
80-971-9780-265-274
90-1092-10990-298-307
100-1214-12200-331-340

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.040.00.00.0%1.079.00.01.3%
Book Value Change Per Share0.04.00.00.0%1.011.00.08.3%5.015.00.025.0%13.027.00.032.5%20.058.02.025.0%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%1.00.079.01.3%
Total Gains per Share0.04.00.00.0%1.011.00.08.3%5.015.00.025.0%13.027.00.032.5%20.058.02.025.0%

Fundamentals of Medicinova

About MediciNova Inc

MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. It is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological and other disorders, such as primary and secondary progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and substance dependence and addiction, as well as prevention of acute respiratory distress syndrome, and long COVID. The company's product pipeline also includes MN-221 (bedoradrine), a selective beta-2-adrenergic receptor agonist for the treatment of acute exacerbations of asthma; MN-001 (tipelukast), an orally bioavailable small molecule compound to treat fibrotic and other diseases, including nonalcoholic fatty liver disease and idiopathic pulmonary fibrosis; and MN-029 (denibulin), a tubulin binding agent for treating solid tumor cancers. It has license agreements with Kyorin Pharmaceutical Co., Ltd; Angiogene Pharmaceuticals, Ltd.; and Meiji Seika Kaisha, Ltd. The company was incorporated in 2000 and is headquartered in La Jolla, California.

Fundamental data was last updated by Penke on 2024-04-11 14:47:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is not making a profit/loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is very efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of MediciNova Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Medicinova earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Medicinova to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of MediciNova Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.0%+0.0%
TTM0.0%YOY-0.0%
TTM0.0%5Y-489.5%+489.5%
5Y-489.5%10Y-245.7%-243.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--207.2%+207.2%
TTM0.0%-216.8%+216.8%
YOY--282.3%+282.3%
5Y-489.5%-436.8%-52.7%
10Y-245.7%-597.3%+351.6%
1.1.2. Return on Assets

Shows how efficient Medicinova is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Medicinova to the Biotechnology industry mean.
  • -3.1% Return on Assets means that Medicinova generated $-0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of MediciNova Inc:

  • The MRQ is -3.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -3.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-3.1%TTM-3.1%0.0%
TTM-3.1%YOY-4.3%+1.2%
TTM-3.1%5Y-3.8%+0.7%
5Y-3.8%10Y-5.2%+1.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.1%-13.3%+10.2%
TTM-3.1%-12.8%+9.7%
YOY-4.3%-11.6%+7.3%
5Y-3.8%-13.8%+10.0%
10Y-5.2%-15.6%+10.4%
1.1.3. Return on Equity

Shows how efficient Medicinova is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Medicinova to the Biotechnology industry mean.
  • -3.3% Return on Equity means Medicinova generated $-0.03 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of MediciNova Inc:

  • The MRQ is -3.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -3.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-3.3%TTM-3.3%0.0%
TTM-3.3%YOY-4.6%+1.3%
TTM-3.3%5Y-4.0%+0.7%
5Y-4.0%10Y-5.9%+1.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.3%-16.9%+13.6%
TTM-3.3%-16.1%+12.8%
YOY-4.6%-14.9%+10.3%
5Y-4.0%-19.3%+15.3%
10Y-5.9%-20.1%+14.2%

1.2. Operating Efficiency of MediciNova Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Medicinova is operating .

  • Measures how much profit Medicinova makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Medicinova to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of MediciNova Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-28.7%+28.7%
TTM-28.7%YOY--28.7%
TTM-28.7%5Y-498.3%+469.7%
5Y-498.3%10Y-250.1%-248.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--298.0%+298.0%
TTM-28.7%-238.5%+209.8%
YOY--288.4%+288.4%
5Y-498.3%-486.2%-12.1%
10Y-250.1%-628.4%+378.3%
1.2.2. Operating Ratio

Measures how efficient Medicinova is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of MediciNova Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.537-0.537
TTM0.537YOY-+0.537
TTM0.5375Y5.133-4.597
5Y5.13310Y2.577+2.557
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.235-3.235
TTM0.5373.310-2.773
YOY-3.838-3.838
5Y5.1335.679-0.546
10Y2.5777.823-5.246

1.3. Liquidity of MediciNova Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Medicinova is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 15.61 means the company has $15.61 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of MediciNova Inc:

  • The MRQ is 15.606. The company is very able to pay all its short-term debts. +2
  • The TTM is 18.532. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ15.606TTM18.532-2.926
TTM18.532YOY17.636+0.896
TTM18.5325Y26.512-7.979
5Y26.51210Y23.411+3.100
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ15.6063.863+11.743
TTM18.5324.169+14.363
YOY17.6365.337+12.299
5Y26.5126.122+20.390
10Y23.4116.434+16.977
1.3.2. Quick Ratio

Measures if Medicinova is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Medicinova to the Biotechnology industry mean.
  • A Quick Ratio of 15.55 means the company can pay off $15.55 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of MediciNova Inc:

  • The MRQ is 15.553. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 18.347. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ15.553TTM18.347-2.794
TTM18.347YOY20.555-2.208
TTM18.3475Y26.848-8.501
5Y26.84810Y23.458+3.390
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ15.5533.504+12.049
TTM18.3473.991+14.356
YOY20.5555.371+15.184
5Y26.8486.088+20.760
10Y23.4586.395+17.063

1.4. Solvency of MediciNova Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Medicinova assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Medicinova to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.06 means that Medicinova assets are financed with 5.9% credit (debt) and the remaining percentage (100% - 5.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of MediciNova Inc:

  • The MRQ is 0.059. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.052. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.059TTM0.052+0.006
TTM0.052YOY0.056-0.003
TTM0.0525Y0.052+0.001
5Y0.05210Y0.088-0.036
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0590.339-0.280
TTM0.0520.337-0.285
YOY0.0560.271-0.215
5Y0.0520.368-0.316
10Y0.0880.388-0.300
1.4.2. Debt to Equity Ratio

Measures if Medicinova is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Medicinova to the Biotechnology industry mean.
  • A Debt to Equity ratio of 6.2% means that company has $0.06 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of MediciNova Inc:

  • The MRQ is 0.062. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.055. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.062TTM0.055+0.007
TTM0.055YOY0.059-0.004
TTM0.0555Y0.054+0.001
5Y0.05410Y0.099-0.045
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0620.392-0.330
TTM0.0550.403-0.348
YOY0.0590.335-0.276
5Y0.0540.427-0.373
10Y0.0990.461-0.362

2. Market Valuation of MediciNova Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Medicinova generates.

  • Above 15 is considered overpriced but always compare Medicinova to the Biotechnology industry mean.
  • A PE ratio of -8.93 means the investor is paying $-8.93 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of MediciNova Inc:

  • The EOD is -7.860. Based on the earnings, the company is expensive. -2
  • The MRQ is -8.932. Based on the earnings, the company is expensive. -2
  • The TTM is -15.818. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-7.860MRQ-8.932+1.072
MRQ-8.932TTM-15.818+6.885
TTM-15.818YOY-8.257-7.561
TTM-15.8185Y-33.616+17.799
5Y-33.61610Y-40.591+6.975
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-7.860-2.300-5.560
MRQ-8.932-2.656-6.276
TTM-15.818-2.718-13.100
YOY-8.257-4.145-4.112
5Y-33.616-6.258-27.358
10Y-40.591-6.315-34.276
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of MediciNova Inc:

  • The EOD is -32.433. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -36.856. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -18.895. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-32.433MRQ-36.856+4.423
MRQ-36.856TTM-18.895-17.960
TTM-18.895YOY-9.365-9.531
TTM-18.8955Y-19.489+0.594
5Y-19.48910Y-30.693+11.203
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-32.433-2.974-29.459
MRQ-36.856-3.306-33.550
TTM-18.895-3.508-15.387
YOY-9.365-5.613-3.752
5Y-19.489-8.378-11.111
10Y-30.693-8.873-21.820
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Medicinova is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.18 means the investor is paying $1.18 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of MediciNova Inc:

  • The EOD is 1.038. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.179. Based on the equity, the company is underpriced. +1
  • The TTM is 1.515. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.038MRQ1.179-0.142
MRQ1.179TTM1.515-0.335
TTM1.515YOY1.534-0.019
TTM1.5155Y2.790-1.275
5Y2.79010Y5.035-2.245
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.0381.914-0.876
MRQ1.1792.116-0.937
TTM1.5152.097-0.582
YOY1.5342.881-1.347
5Y2.7903.550-0.760
10Y5.0353.936+1.099
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of MediciNova Inc.

3.1. Institutions holding MediciNova Inc

Institutions are holding 21.158% of the shares of MediciNova Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Essex Woodlands Health Ventures2.25490.4105110594100
2023-12-31BlackRock Inc1.4265069964240450.5815
2023-12-31Vanguard Group Inc1.2709062333364901.0521
2023-12-31Citigroup Inc0.91330.000544795700
2023-12-31Geode Capital Management, LLC0.88840.000143573300
2023-12-31Renaissance Technologies Corp0.3550.00041741002450016.377
2023-12-31Bank of America Corp0.342501679598130093.816
2023-12-31State Street Corporation0.320501571981490010.471
2023-12-31Northern Trust Corp0.31310153556-143-0.093
2023-12-31Dimensional Fund Advisors, Inc.0.3110.0001152530-5412-3.4266
2023-12-31Bridgeway Capital Management, LLC0.29590.004714514700
2023-12-31JPMorgan Chase & Co0.27210133433-1943-1.4353
2023-12-31Bank of New York Mellon Corp0.24450119894-99-0.0825
2023-12-31Barclays PLC0.18620.000191300-12500-12.0424
2023-09-30Schonfeld Strategic Advisors LLC0.0860.000742200-100-0.2364
2023-12-31Millennium Management LLC0.0742036390-178416-83.0591
2023-12-31Goldman Sachs Group Inc0.0446021888218880
2023-12-31Susquehanna International Group, LLP0.0443021745861165.5627
2023-12-31T. Rowe Price Associates, Inc.0.042202070000
2023-12-31Bank Julius Baer & Co. Ltd, Zurich0.03870.000219000190000
Total 9.72480.41734769646-17879-0.4%

3.2. Funds holding MediciNova Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.23910.000860773400
2024-02-29Fidelity Extended Market Index0.51490.0009252547-1224-0.4823
2023-12-31Bridgeway Ultra-Small Company Market0.28590.113214024700
2024-03-28iShares Micro-Cap ETF0.20820.016110212600
2023-09-30BlackRock Extended Mkt Composite0.19550.00149588100
2024-03-31BlackRock Extended Equity Market K0.17060.000883678300.0359
2024-02-29Fidelity Total Market Index0.12510.00016134000
2024-02-29Fidelity Series Total Market Index0.12470.00016114200
2023-12-31Northern Trust Extended Eq Market Idx0.08540.00114189300
2023-12-31NT Ext Equity Mkt Idx Fd - L0.08540.00114189300
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.07490.00093673500
2024-02-29DFA US Core Equity 2 I0.07070.00013467000
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.06020.000929503550.1868
2024-02-29Fidelity Nasdaq Composite Index0.05290.00022596600
2024-02-29DFA US Vector Equity I0.05270.00072586900
2023-12-31Northern Small Cap Core K0.05250.00842573100
2024-03-29Dimensional US Core Equity 2 ETF0.04660.00012285600
2024-02-29Spartan Total Market Index Pool E0.04520.00012219100
2023-12-31T. Rowe Price U.S. Equities Tr0.04220.00032070000
2024-02-29Schwab Total Stock Market Index0.03640.00011784300
Total 3.56910.14741750545-1139-0.1%

3.3. Insider Transactions

Insiders are holding 2.56% of the shares of MediciNova Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2022-11-28Hideki NagaoSELL67542.25
2022-11-17Hideki NagaoSELL3092.18

4. Summary

4.1. Key Performance Indicators

The key performance indicators of MediciNova Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.047-0.040-14%-0.068+47%-0.011-77%0.019-348%
Book Value Per Share--1.2721.325-4%1.531-17%1.528-17%1.166+9%
Current Ratio--15.60618.532-16%17.636-12%26.512-41%23.411-33%
Debt To Asset Ratio--0.0590.052+12%0.056+6%0.052+14%0.088-33%
Debt To Equity Ratio--0.0620.055+13%0.059+6%0.054+15%0.099-37%
Dividend Per Share----0%-0%-0%-0%
Eps---0.042-0.044+4%-0.072+71%-0.061+45%-0.058+39%
Free Cash Flow Per Share---0.010-0.038+273%-0.066+547%-0.051+399%-0.040+295%
Free Cash Flow To Equity Per Share---0.010-0.038+273%-0.066+545%-0.011+13%0.022-146%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--0.311--------
Intrinsic Value_10Y_min---0.516--------
Intrinsic Value_1Y_max---0.133--------
Intrinsic Value_1Y_min---0.178--------
Intrinsic Value_3Y_max---0.275--------
Intrinsic Value_3Y_min---0.428--------
Intrinsic Value_5Y_max---0.265--------
Intrinsic Value_5Y_min---0.561--------
Market Cap64740984.000-14%73569369.00098705570.075-25%115503849.530-36%209635748.571-65%246144499.586-70%
Net Profit Margin---0.0000%-0%-4.8950%-2.4570%
Operating Margin----0.2870%-0%-4.9830%-2.5010%
Operating Ratio---0.537-100%-0%5.133-100%2.577-100%
Pb Ratio1.038-14%1.1791.515-22%1.534-23%2.790-58%5.035-77%
Pe Ratio-7.860+12%-8.932-15.818+77%-8.257-8%-33.616+276%-40.591+354%
Price Per Share1.320-14%1.5002.013-25%2.355-36%4.274-65%5.019-70%
Price To Free Cash Flow Ratio-32.433+12%-36.856-18.895-49%-9.365-75%-19.489-47%-30.693-17%
Price To Total Gains Ratio-28.261+12%-32.115-80.192+150%-34.515+7%1.229-2714%464.245-107%
Quick Ratio--15.55318.347-15%20.555-24%26.848-42%23.458-34%
Return On Assets---0.031-0.0310%-0.043+39%-0.038+21%-0.052+69%
Return On Equity---0.033-0.033-1%-0.046+39%-0.040+21%-0.059+78%
Total Gains Per Share---0.047-0.040-14%-0.068+47%-0.011-77%0.019-348%
Usd Book Value--62378424.00064987464.250-4%75079480.000-17%74933323.400-17%57187278.250+9%
Usd Book Value Change Per Share---0.047-0.040-14%-0.068+47%-0.011-77%0.019-348%
Usd Book Value Per Share--1.2721.325-4%1.531-17%1.528-17%1.166+9%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.042-0.044+4%-0.072+71%-0.061+45%-0.058+39%
Usd Free Cash Flow---499038.000-1863084.250+273%-3229143.250+547%-2488771.100+399%-1969500.350+295%
Usd Free Cash Flow Per Share---0.010-0.038+273%-0.066+547%-0.051+399%-0.040+295%
Usd Free Cash Flow To Equity Per Share---0.010-0.038+273%-0.066+545%-0.011+13%0.022-146%
Usd Market Cap64740984.000-14%73569369.00098705570.075-25%115503849.530-36%209635748.571-65%246144499.586-70%
Usd Price Per Share1.320-14%1.5002.013-25%2.355-36%4.274-65%5.019-70%
Usd Profit---2059085.000-2131444.250+4%-3434817.000+67%-2959742.600+44%-2848485.625+38%
Usd Revenue---250000000.000-100%-0%251964119.500-100%126132059.750-100%
Usd Total Gains Per Share---0.047-0.040-14%-0.068+47%-0.011-77%0.019-348%
 EOD+3 -5MRQTTM+13 -18YOY+19 -105Y+14 -1710Y+17 -14

4.2. Fundamental Score

Let's check the fundamental score of MediciNova Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-7.860
Price to Book Ratio (EOD)Between0-11.038
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than115.553
Current Ratio (MRQ)Greater than115.606
Debt to Asset Ratio (MRQ)Less than10.059
Debt to Equity Ratio (MRQ)Less than10.062
Return on Equity (MRQ)Greater than0.15-0.033
Return on Assets (MRQ)Greater than0.05-0.031
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of MediciNova Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose1.370
Total1/1 (100.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets66,270
Total Liabilities3,892
Total Stockholder Equity62,378
 As reported
Total Liabilities 3,892
Total Stockholder Equity+ 62,378
Total Assets = 66,270

Assets

Total Assets66,270
Total Current Assets51,174
Long-term Assets15,096
Total Current Assets
Cash And Cash Equivalents 50,999
Other Current Assets 175
Total Current Assets  (as reported)51,174
Total Current Assets  (calculated)51,174
+/-0
Long-term Assets
Property Plant Equipment 621
Goodwill 9,600
Intangible Assets 4,800
Long-term Assets Other 74
Long-term Assets  (as reported)15,096
Long-term Assets  (calculated)15,096
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities3,279
Long-term Liabilities612
Total Stockholder Equity62,378
Total Current Liabilities
Short-term Debt 216
Accounts payable 1,004
Other Current Liabilities 164
Total Current Liabilities  (as reported)3,279
Total Current Liabilities  (calculated)1,384
+/- 1,895
Long-term Liabilities
Capital Lease Obligations 216
Long-term Liabilities Other 411
Long-term Liabilities  (as reported)612
Long-term Liabilities  (calculated)627
+/- 14
Total Stockholder Equity
Common Stock49
Retained Earnings -415,702
Accumulated Other Comprehensive Income -118
Other Stockholders Equity 478,149
Total Stockholder Equity (as reported)62,378
Total Stockholder Equity (calculated)62,378
+/-0
Other
Capital Stock49
Cash and Short Term Investments 50,999
Common Stock Shares Outstanding 49,046
Current Deferred Revenue1,895
Liabilities and Stockholders Equity 66,270
Net Debt -50,784
Net Invested Capital 62,378
Net Working Capital 47,895
Property Plant and Equipment Gross 1,065
Short Long Term Debt Total 216



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-31
> Total Assets 
0
0
57,016
53,769
159,726
154,578
147,964
142,394
134,498
126,990
121,756
111,591
106,686
90,631
83,006
73,752
63,800
57,957
51,879
50,224
64,187
59,857
55,949
94,327
85,701
83,631
76,672
72,934
75,438
27,156
24,640
30,787
26,913
23,035
21,500
19,568
18,846
27,677
26,197
29,546
31,217
29,564
27,787
27,273
25,468
24,719
39,587
37,906
43,859
42,363
40,778
39,813
37,424
38,456
40,108
43,419
78,665
79,077
77,275
77,223
78,548
77,152
78,224
79,205
77,014
75,838
77,293
75,419
96,101
93,684
91,624
87,406
84,175
81,236
78,392
74,155
71,133
68,719
68,137
66,270
66,27068,13768,71971,13374,15578,39281,23684,17587,40691,62493,68496,10175,41977,29375,83877,01479,20578,22477,15278,54877,22377,27579,07778,66543,41940,10838,45637,42439,81340,77842,36343,85937,90639,58724,71925,46827,27327,78729,56431,21729,54626,19727,67718,84619,56821,50023,03526,91330,78724,64027,15675,43872,93476,67283,63185,70194,32755,94959,85764,18750,22451,87957,95763,80073,75283,00690,631106,686111,591121,756126,990134,498142,394147,964154,578159,72653,76957,01600
   > Total Current Assets 
0
0
55,678
51,289
159,246
154,058
147,038
141,259
133,406
125,917
120,728
110,670
105,873
89,764
82,206
73,079
63,234
57,464
48,566
20,016
34,014
56,624
53,262
46,923
40,345
38,495
62,281
58,344
60,882
12,714
9,558
15,708
11,804
7,893
6,345
4,422
3,713
12,498
11,039
14,383
16,062
14,405
12,631
12,133
10,337
9,602
24,345
22,726
28,687
27,221
25,612
24,704
22,324
23,363
25,010
28,328
63,572
64,606
62,811
62,758
63,764
62,250
63,274
64,305
62,166
61,046
62,555
60,717
81,468
78,910
76,160
72,009
68,831
65,957
53,149
58,987
56,034
53,522
52,996
51,174
51,17452,99653,52256,03458,98753,14965,95768,83172,00976,16078,91081,46860,71762,55561,04662,16664,30563,27462,25063,76462,75862,81164,60663,57228,32825,01023,36322,32424,70425,61227,22128,68722,72624,3459,60210,33712,13312,63114,40516,06214,38311,03912,4983,7134,4226,3457,89311,80415,7089,55812,71460,88258,34462,28138,49540,34546,92353,26256,62434,01420,01648,56657,46463,23473,07982,20689,764105,873110,670120,728125,917133,406141,259147,038154,058159,24651,28955,67800
       Cash And Cash Equivalents 
0
0
54,083
38,801
81,493
27,922
20,101
37,678
19,860
15,075
38,299
8,334
6,946
12,654
14,857
18,779
28,128
28,035
23,079
19,297
32,790
28,657
25,645
19,242
15,597
25,357
31,163
28,252
31,380
11,922
8,736
15,093
11,006
7,259
5,745
4,011
3,029
12,017
10,661
6,700
14,784
13,497
11,937
11,669
9,073
8,581
23,612
22,077
27,618
26,565
24,972
24,118
21,637
22,890
24,535
27,992
62,939
64,163
62,442
62,313
63,210
61,738
62,873
63,793
61,330
60,440
61,661
60,037
76,302
77,792
75,025
71,431
67,695
65,233
52,507
18,505
55,259
52,876
51,507
50,999
50,99951,50752,87655,25918,50552,50765,23367,69571,43175,02577,79276,30260,03761,66160,44061,33063,79362,87361,73863,21062,31362,44264,16362,93927,99224,53522,89021,63724,11824,97226,56527,61822,07723,6128,5819,07311,66911,93713,49714,7846,70010,66112,0173,0294,0115,7457,25911,00615,0938,73611,92231,38028,25231,16325,35715,59719,24225,64528,65732,79019,29723,07928,03528,12818,77914,85712,6546,9468,33438,29915,07519,86037,67820,10127,92281,49338,80154,08300
       Short-term Investments 
0
0
1,250
12,000
75,900
123,972
125,077
101,023
111,522
108,434
78,922
95,717
91,179
73,206
61,099
51,857
33,541
27,804
24,372
0
0
21,269
21,390
26,812
23,700
11,490
840
624
624
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
39,982
0
0
0
0
000039,982000000000000000000000000000000000000000000000062462484011,49023,70026,81221,39021,2690024,37227,80433,54151,85761,09973,20691,17995,71778,922108,434111,522101,023125,077123,97275,90012,0001,25000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,009
6,009
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,000
0
0
0
0
0
0
0
0
0
1,000
0
01,0000000000004,0000000000000000000000000000006,0096,009000000000000000000000000000000000000000
       Other Current Assets 
0
0
345
488
1,853
2,163
1,860
2,559
2,023
2,408
3,507
6,619
7,748
3,904
6,249
2,444
1,566
1,625
1,115
718
1,224
5,642
5,335
870
1,048
500
1,137
0
29,502
792
822
615
798
634
600
412
684
480
378
1,674
1,278
908
694
463
1,264
1,021
733
649
1,069
656
640
586
687
473
475
337
633
443
368
445
554
513
402
512
836
606
894
680
1,166
1,117
1,135
578
1,136
724
642
499
775
645
489
175
1754896457754996427241,1365781,1351,1171,1666808946068365124025135544453684436333374754736875866406561,0696497331,0211,2644636949081,2781,67437848068441260063479861582279229,50201,1375001,0488705,3355,6421,2247181,1151,6251,5662,4446,2493,9047,7486,6193,5072,4082,0232,5591,8602,1631,85348834500
   > Long-term Assets 
0
0
1,338
2,480
480
519
926
1,134
1,093
1,073
1,028
921
813
867
800
673
566
493
3,313
30,208
30,172
3,233
2,686
47,404
45,356
45,136
14,391
14,590
14,556
14,442
15,082
15,080
15,109
15,142
15,155
15,146
15,133
15,179
15,158
15,164
15,155
15,160
15,156
15,141
15,130
15,117
15,242
15,180
15,171
15,142
15,166
15,109
15,100
15,093
15,097
15,091
15,093
14,471
14,465
14,464
14,784
14,901
14,950
14,901
14,849
14,792
14,738
14,702
14,633
14,774
15,464
15,398
15,344
15,279
25,243
15,168
15,098
15,197
15,140
15,096
15,09615,14015,19715,09815,16825,24315,27915,34415,39815,46414,77414,63314,70214,73814,79214,84914,90114,95014,90114,78414,46414,46514,47115,09315,09115,09715,09315,10015,10915,16615,14215,17115,18015,24215,11715,13015,14115,15615,16015,15515,16415,15815,17915,13315,14615,15515,14215,10915,08015,08214,44214,55614,59014,39145,13645,35647,4042,6863,23330,17230,2083,3134935666738008678139211,0281,0731,0931,1349265194802,4801,33800
       Property Plant Equipment 
0
0
269
308
480
519
926
1,134
1,093
1,073
1,028
871
813
867
800
673
566
493
427
368
306
263
204
154
118
90
76
65
53
41
32
29
29
62
88
78
70
106
81
82
76
66
55
45
36
27
24
20
39
46
77
91
84
77
70
63
65
60
53
53
49
45
39
41
38
33
29
56
49
69
946
882
832
773
719
675
621
724
669
621
62166972462167571977383288294669495629333841394549535360656370778491774639202427364555667682811067078886229293241536576901181542042633063684274935666738008678138711,0281,0731,0931,13492651948030826900
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,142
9,142
9,368
9,368
9,600
9,600
9,600
9,600
9,600
9,600
9,600
9,600
9,600
9,600
9,600
9,600
9,600
9,600
9,600
9,600
9,600
9,600
9,600
9,600
9,600
9,600
9,600
9,600
9,600
9,600
9,600
9,600
9,600
9,600
9,600
9,600
9,600
9,600
9,600
9,600
9,600
9,600
9,600
9,600
9,600
9,600
9,600
9,600
9,600
9,600
9,600
9,600
9,600
9,600
9,600
9,600
9,600
9,6009,6009,6009,6009,6009,6009,6009,6009,6009,6009,6009,6009,6009,6009,6009,6009,6009,6009,6009,6009,6009,6009,6009,6009,6009,6009,6009,6009,6009,6009,6009,6009,6009,6009,6009,6009,6009,6009,6009,6009,6009,6009,6009,6009,6009,6009,6009,6009,6009,6009,6009,6009,6009,3689,3689,1429,14200000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
650
650
680
679
666
667
663
673
676
681
679
683
690
685
684
680
660
650
650
636
632
618
616
617
617
617
617
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,022
0
0
0
0
0
0000010,02200000000000000000617617617617616618632636650650660680684685690683679681676673663667666679680650650000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13,942
13,942
14,168
14,169
14,400
14,400
14,401
4,800
4,800
4,800
4,800
4,800
4,800
4,800
4,800
4,800
4,800
4,800
4,800
4,800
4,800
4,800
4,800
4,800
4,800
4,800
4,800
4,800
4,800
4,800
4,800
4,800
4,800
4,800
4,800
4,800
4,800
4,800
4,800
4,800
4,800
4,800
4,800
4,800
4,800
4,800
4,800
4,800
4,800
4,800
4,800
4,800
4,800
4,800
4,800
4,800
4,800
4,8004,8004,8004,8004,8004,8004,8004,8004,8004,8004,8004,8004,8004,8004,8004,8004,8004,8004,8004,8004,8004,8004,8004,8004,8004,8004,8004,8004,8004,8004,8004,8004,8004,8004,8004,8004,8004,8004,8004,8004,8004,8004,8004,8004,8004,8004,8004,8004,8004,80014,40114,40014,40014,16914,16813,94213,94200000000000000000000000
       Other Assets 
0
0
0
2,172
0
0
0
0
0
0
0
50
0
0
0
0
0
0
2,886
29,840
29,867
2,970
2,483
47,249
45,238
45,046
14,315
14,525
14,503
14,401
15,050
15,050
15,080
15,080
15,067
15,067
15,063
15,073
15,077
15,081
15,079
15,093
15,101
15,095
15,095
15,090
15,218
15,160
15,133
15,096
15,089
15,018
15,016
15,016
15,028
15,028
15,028
11
11
11
35
-44
110
60
410
359
309
5,046
183
305
118
97,888
112
105
102
93
0
73
0
0
007309310210511297,8881183051835,04630935941060110-443511111115,02815,02815,02815,01615,01615,01815,08915,09615,13315,16015,21815,09015,09515,09515,10115,09315,07915,08115,07715,07315,06315,06715,06715,08015,08015,05015,05014,40114,50314,52514,31545,04645,23847,2492,4832,97029,86729,8402,8860000005000000002,172000
> Total Liabilities 
0
0
2,026
46,099
3,282
5,258
5,027
6,686
7,329
6,790
9,743
10,610
10,024
12,564
14,245
7,144
7,058
5,314
3,773
2,179
20,446
20,137
20,096
54,313
48,593
49,339
47,454
48,230
48,273
4,407
5,388
7,290
6,334
5,164
4,799
4,688
4,598
4,726
4,750
4,120
4,567
4,763
4,803
5,263
4,522
4,774
4,961
5,153
4,718
4,991
5,032
5,281
4,673
5,070
5,388
4,777
3,095
3,488
3,724
4,115
3,510
3,970
3,873
4,311
3,818
4,745
3,740
4,093
3,729
4,450
5,142
3,729
3,811
4,630
5,286
3,913
3,407
3,543
3,467
3,892
3,8923,4673,5433,4073,9135,2864,6303,8113,7295,1424,4503,7294,0933,7404,7453,8184,3113,8733,9703,5104,1153,7243,4883,0954,7775,3885,0704,6735,2815,0324,9914,7185,1534,9614,7744,5225,2634,8034,7634,5674,1204,7504,7264,5984,6884,7995,1646,3347,2905,3884,40748,27348,23047,45449,33948,59354,31320,09620,13720,4462,1793,7735,3147,0587,14414,24512,56410,02410,6109,7436,7907,3296,6865,0275,2583,28246,0992,02600
   > Total Current Liabilities 
0
0
2,013
2,585
3,231
5,198
4,968
6,626
7,273
6,739
9,697
10,569
9,991
12,540
14,231
7,141
7,058
5,314
3,773
2,179
20,446
20,137
20,096
22,423
18,394
7,264
34,145
36,790
46,317
2,451
3,432
3,697
2,742
3,208
1,157
1,038
948
1,076
1,099
460
902
1,096
1,135
1,594
853
1,107
1,297
1,491
1,050
1,333
1,375
1,630
1,022
1,420
1,738
2,881
1,199
1,568
1,805
2,192
1,374
1,790
1,734
2,228
1,795
2,774
1,804
2,194
1,831
2,467
4,202
2,833
2,976
3,841
4,528
3,187
2,715
2,821
2,802
3,279
3,2792,8022,8212,7153,1874,5283,8412,9762,8334,2022,4671,8312,1941,8042,7741,7952,2281,7341,7901,3742,1921,8051,5681,1992,8811,7381,4201,0221,6301,3751,3331,0501,4911,2971,1078531,5941,1351,0969024601,0991,0769481,0381,1573,2082,7423,6973,4322,45146,31736,79034,1457,26418,39422,42320,09620,13720,4462,1793,7735,3147,0587,14114,23112,5409,99110,5699,6976,7397,2736,6264,9685,1983,2312,5852,01300
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
17,859,881
17,650,538
17,605
14,443
4,181
3,543
33,578
28,622
0
0
0
0
0
257
0
-1,694,163
-1,694,163
0
-1,694,163
-1,694,163
-1,694,163
-1,694,163
-1,694,163
-1,694,163
-1,694,163
-1,694,163
-1,694,163
-1,694,163
-1,694,163
-1,694,163
-1,694,163
-1,694,163
-1,694,163
-1,694,163
-1,694,163
-1,694,163
-1,694,163
-1,694,163
-1,694,163
-1,694,163
-1,694,163
-1,694,163
-1,694,163
-1,694,163
-1,694,163
-1,694,163
28,622
-1,694,163
-1,694,163
151
132
164
184
167
158
142
201
205
216
216205201142158167184164132151-1,694,163-1,694,16328,622-1,694,163-1,694,163-1,694,163-1,694,163-1,694,163-1,694,163-1,694,163-1,694,163-1,694,163-1,694,163-1,694,163-1,694,163-1,694,163-1,694,163-1,694,163-1,694,163-1,694,163-1,694,163-1,694,163-1,694,163-1,694,163-1,694,163-1,694,163-1,694,163-1,694,163-1,694,163-1,694,163-1,694,1630-1,694,163-1,694,16302570000028,62233,5783,5434,18114,44317,60517,650,53817,859,881000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
112
190
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000190112000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
436
470
1,078
1,090
867
1,380
1,752
1,492
1,771
3,828
4,323
3,020
2,970
2,880
1,115
717
370
393
949
422
430
1,300
1,042
515
579
1,100
874
329
1,077
719
309
440
333
492
270
131
187
34
154
38
318
462
110
178
355
171
77
210
266
367
158
300
302
1,520
361
352
608
617
254
328
230
451
378
577
376
617
428
607
642
403
665
643
553
425
585
548
737
1,004
1,0047375485854255536436654036426074286173765773784512303282546176083523611,5203023001583672662107717135517811046231838154341871312704923334403097191,0773298741,1005795151,0421,3004304229493933707171,1152,8802,9703,0204,3233,8281,7711,4921,7521,3808671,0901,07847043600
       Other Current Liabilities 
0
0
1,577
2,115
2,153
4,108
4,101
5,246
5,522
5,247
7,926
6,740
5,668
9,520
11,262
4,260
5,943
4,597
3,404
1,787
19,497
19,715
19,666
1,094
952
1,094
28,549
624
13,752
2,121
2,355
2,115
1,760
952
522
543
678
945
913
427
748
1,058
817
1,132
743
929
942
1,320
973
1,124
1,109
1,263
864
1,119
1,436
1,361
838
1,216
1,196
1,575
1,120
1,462
1,503
1,777
1,417
2,197
1,428
-28,738
1,403
1,859
1,715
547
2,147
3,014
3,808
2,605
1,988
2,071,738
1,859,389
164
1641,859,3892,071,7381,9882,6053,8083,0142,1475471,7151,8591,403-28,7381,4282,1971,4171,7771,5031,4621,1201,5751,1961,2168381,3611,4361,1198641,2631,1091,1249731,3209429297431,1328171,0587484279139456785435229521,7602,1152,3552,12113,75262428,5491,0949521,09419,66619,71519,4971,7873,4044,5975,9434,26011,2629,5205,6686,7407,9265,2475,5225,2464,1014,1082,1532,1151,57700
   > Long-term Liabilities 
0
0
13
43,514
51
59
59
60
56
51
46
41
33
23
13
3
3
0
0
0
0
0
0
31,891
30,199
42,075
13,309
11,440
1,956
1,956
1,956
3,592
3,592
1,956
3,642
3,650
3,650
3,650
3,650
3,660
3,665
3,667
3,668
3,669
3,668
3,667
3,665
3,663
3,669
3,657
3,657
3,651
3,651
3,650
3,650
1,896
1,896
1,920
1,919
1,923
2,136
2,180
2,139
2,082
2,024
1,972
1,936
1,899
1,898
1,983
940
896
835
789
758
725
691
721
666
612
6126667216917257587898358969401,9831,8981,8991,9361,9722,0242,0822,1392,1802,1361,9231,9191,9201,8961,8963,6503,6503,6513,6513,6573,6573,6693,6633,6653,6673,6683,6693,6683,6673,6653,6603,6503,6503,6503,6503,6421,9563,5923,5921,9561,9561,95611,44013,30942,07530,19931,89100000033132333414651566059595143,5141300
       Other Liabilities 
0
0
0
31
51
60
59
60
56
51
46
41
33
23
13
3
0
0
0
0
0
0
0
677
649
643
636
0
0
0
0
1,636
1,636
0
1,686
1,694
1,695
1,694
1,695
1,703
1,709
1,711
1,712
1,713
1,712
1,711
1,708
1,706
1,713
1,701
1,701
1,695
1,695
1,694
1,694
1,694
1,694
1,920
1,919
1,923
1,900
1,901
1,900
1,900
1,896
1,896
1,896
1,899
1,898
1,983
940
202
202
789
758
202
0
202
0
0
0020202027587892022029401,9831,8981,8991,8961,8961,8961,9001,9001,9011,9001,9231,9191,9201,6941,6941,6941,6941,6951,6951,7011,7011,7131,7061,7081,7111,7121,7131,7121,7111,7091,7031,6951,6941,6951,6941,68601,6361,636000063664364967700000003132333414651566059605131000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,956
1,956
3,592
3,592
1,956
3,642
3,650
3,650
3,650
3,650
3,660
3,665
3,667
3,668
3,669
3,668
3,667
3,665
3,663
3,669
3,657
3,657
3,651
3,651
3,650
3,650
1,896
1,896
1,920
1,919
1,923
1,896
1,896
1,896
1,896
1,896
1,896
1,896
1,896
1,896
1,896
202
202
202
202
202
202
202
202
0
0
002022022022022022022022021,8961,8961,8961,8961,8961,8961,8961,8961,8961,8961,9231,9191,9201,8961,8963,6503,6503,6513,6513,6573,6573,6693,6633,6653,6673,6683,6693,6683,6673,6653,6603,6503,6503,6503,6503,6421,9563,5923,5921,9561,95600000000000000000000000000000
> Total Stockholder Equity
0
0
54,991
7,669
156,444
149,320
142,937
135,708
127,169
120,200
112,013
100,981
96,662
78,068
68,762
66,608
56,742
52,643
48,106
48,045
43,741
39,720
35,853
40,013
37,108
34,291
29,218
24,704
27,165
22,749
19,253
23,498
20,579
17,871
16,701
14,880
14,247
22,951
21,447
25,426
26,650
24,801
22,985
22,011
20,946
19,945
34,626
32,753
39,140
37,373
35,746
34,532
32,751
33,386
34,720
38,642
75,570
75,589
73,552
73,108
75,037
73,182
74,351
74,895
73,196
71,093
73,553
71,327
92,371
89,234
86,482
83,677
80,364
76,606
73,106
70,242
67,726
65,176
64,669
62,378
62,37864,66965,17667,72670,24273,10676,60680,36483,67786,48289,23492,37171,32773,55371,09373,19674,89574,35173,18275,03773,10873,55275,58975,57038,64234,72033,38632,75134,53235,74637,37339,14032,75334,62619,94520,94622,01122,98524,80126,65025,42621,44722,95114,24714,88016,70117,87120,57923,49819,25322,74927,16524,70429,21834,29137,10840,01335,85339,72043,74148,04548,10652,64356,74266,60868,76278,06896,662100,981112,013120,200127,169135,708142,937149,320156,4447,66954,99100
   Common Stock
0
0
1
1
99
99
99
99
101
102
10
10
12
12
12
12
12
12
12
12
12
12
12
12
12
12
12
12
15
15
15
16
16
16
17
17
18
22
22
22
24
24
24
24
25
25
30
30
32
34
34
35
35
35
36
36
41
42
42
42
43
43
43
44
44
44
45
45
49
49
49
49
49
49
49
49
49
49
49
49
49494949494949494949494945454444444343434242424136363535353434323030252524242424222222181717161616151515121212121212121212121212121212121010102101999999991100
   Retained Earnings Total Equity00-412,920-410,048-407,130-404,129-400,477-396,448-393,061-390,978-387,399-383,115-382,927-379,942-376,238-371,787-369,073-367,089-364,710-360,828-356,131-355,923-349,143-345,999-341,456-339,853-336,098-333,310-330,293-328,844-326,008-322,809-319,427-316,692-315,084-312,797-310,582-308,201-305,861-303,739-301,387-303,676-301,439-298,653-296,234-293,800-291,421-289,140-285,272-281,769-277,87500000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
-1,197
-1,195
-1,109
-1,006
-926
-815
-14
-11
-66
-49
-26
-13
9
-131
-33
-45
-593
-30
-69
-68
-60
-65
-66
-63
-56
-56
-63
-61
-56
-57
-64
-62
-59
-68
-75
-79
-78
-81
-78
-77
-84
-101
-102
-103
-101
-103
-93
-88
-85
-96
-94
-95
-94
-95
-89
-93
-93
-93
-95
-92
-92
-93
-93
-93
-90
-88
-95
-94
-95
-99
-106
-118
-124
-115
-117
-121
-124
-118
-118-124-121-117-115-124-118-106-99-95-94-95-88-90-93-93-93-92-92-95-93-93-93-89-95-94-95-94-96-85-88-93-103-101-103-102-101-84-77-78-81-78-79-75-68-59-62-64-57-56-61-63-56-56-63-66-65-60-68-69-30-593-45-33-1319-13-26-49-66-11-14-815-926-1,006-1,109-1,195-1,19700
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
301,864
302,252
309,998
310,926
310,497
311,671
312,293
314,079
325,568
326,300
326,869
330,441
330,713
331,244
332,667
333,818
335,105
351,387
352,251
362,007
363,434
364,640
364,886
366,121
369,544
374,632
380,157
421,617
424,783
429,527
429,290
435,918
437,940
441,489
444,016
445,032
447,379
453,540
454,297
475,532
476,678
477,506
476,788
476,869
477,151
477,310
477,438
477,842
478,167
0
0
00478,167477,842477,438477,310477,151476,869476,788477,506476,678475,532454,297453,540447,379445,032444,016441,489437,940435,918429,290429,527424,783421,617380,157374,632369,544366,121364,886364,640363,434362,007352,251351,387335,105333,818332,667331,244330,713330,441326,869326,300325,568314,079312,293311,671310,497310,926309,998302,252301,86400000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000-1,124-1,124-1,124-1,131-1,131-1,162-1,162-1,190-1,190-1,194-1,194-1,198-1,198-1,212-1,212-1,235-1,235-1,276-1,276-1,317-1,317-1,361-1,361-1,404-1,404-1,438-1,438-1,438-1,260-1,040-875-550000000
   Other Stockholders Equity 
0
0
103,521
103,603
256,016
256,095
256,155
256,286
256,194
256,458
256,724
257,773
269,356
270,542
271,464
272,752
273,688
274,481
274,759
276,406
275,705
276,349
277,276
288,932
289,608
291,125
291,752
293,678
300,344
300,609
301,007
308,809
309,764
309,336
310,540
311,162
312,955
324,444
325,176
326,869
330,441
330,713
331,244
332,667
333,818
335,105
351,387
352,251
362,007
363,346
364,555
365,290
366,026
369,449
374,537
380,534
421,528
424,690
429,433
429,680
435,823
437,849
441,396
444,422
444,939
447,286
453,540
454,732
475,532
476,678
477,506
476,788
476,869
477,151
477,310
477,438
477,842
478,167
478,387
478,149
478,149478,387478,167477,842477,438477,310477,151476,869476,788477,506476,678475,532454,732453,540447,286444,939444,422441,396437,849435,823429,680429,433424,690421,528380,534374,537369,449366,026365,290364,555363,346362,007352,251351,387335,105333,818332,667331,244330,713330,441326,869325,176324,444312,955311,162310,540309,336309,764308,809301,007300,609300,344293,678291,752291,125289,608288,932277,276276,349275,705276,406274,759274,481273,688272,752271,464270,542269,356257,773256,724256,458256,194256,286256,155256,095256,016103,603103,52100



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,000
Cost of Revenue-20
Gross Profit980980
 
Operating Income (+$)
Gross Profit980
Operating Expense-10,900
Operating Income-9,900-9,921
 
Operating Expense (+$)
Research Development5,658
Selling General Administrative5,242
Selling And Marketing Expenses0
Operating Expense10,90010,900
 
Net Interest Income (+$)
Interest Income1,835
Interest Expense-0
Other Finance Cost-0
Net Interest Income1,835
 
Pretax Income (+$)
Operating Income-9,900
Net Interest Income1,835
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-8,568-9,397
EBIT - interestExpense = -9,900
-8,568
-8,572
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-9,900-8,568
Earnings Before Interest and Taxes (EBITDA)-9,880
 
After tax Income (+$)
Income Before Tax-8,568
Tax Provision-3
Net Income From Continuing Ops-8,572-8,572
Net Income-8,572
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses10,900
Total Other Income/Expenses Net-503-1,835
 

Technical Analysis of Medicinova
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Medicinova. The general trend of Medicinova is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Medicinova's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of MediciNova Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.6399 < 1.7 < 2.09.

The bearish price targets are: 1.3 > 1.26 > 1.26.

Tweet this
MediciNova Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of MediciNova Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

MediciNova Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of MediciNova Inc.

MediciNova Inc Daily Moving Average Convergence/Divergence (MACD) ChartMediciNova Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of MediciNova Inc. The current adx is .

MediciNova Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of MediciNova Inc.

MediciNova Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of MediciNova Inc.

MediciNova Inc Daily Relative Strength Index (RSI) ChartMediciNova Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of MediciNova Inc.

MediciNova Inc Daily Stochastic Oscillator ChartMediciNova Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of MediciNova Inc.

MediciNova Inc Daily Commodity Channel Index (CCI) ChartMediciNova Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of MediciNova Inc.

MediciNova Inc Daily Chande Momentum Oscillator (CMO) ChartMediciNova Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of MediciNova Inc.

MediciNova Inc Daily Williams %R ChartMediciNova Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of MediciNova Inc.

MediciNova Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of MediciNova Inc.

MediciNova Inc Daily Average True Range (ATR) ChartMediciNova Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of MediciNova Inc.

MediciNova Inc Daily On-Balance Volume (OBV) ChartMediciNova Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of MediciNova Inc.

MediciNova Inc Daily Money Flow Index (MFI) ChartMediciNova Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for MediciNova Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-18MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-27RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-23BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-11CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-14MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-26CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-02STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-11WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

MediciNova Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of MediciNova Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose1.370
Total1/1 (100.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Medicinova with someone you think should read this too:
  • Are you bullish or bearish on Medicinova? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Medicinova? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about MediciNova Inc

I send you an email if I find something interesting about MediciNova Inc.


Comments

How you think about this?

Leave a comment

Stay informed about MediciNova Inc.

Receive notifications about MediciNova Inc in your mailbox!